Table 7 |
||||||
|
Levels of individual biomarkers comprising principal component 3 stratified by smoking status |
||||||
|
Smoking status |
||||||
|
|
||||||
|
Variable (pg/ml) |
Never (n = 61) |
Past (n = 56) |
Current (n = 40) |
P valuea |
Ever (n = 96) |
P valueb |
|
|
||||||
|
MMP-8 |
9,750 (4,767 to 14,668) |
12,578 (6,906 to 26,066) |
18,934 (10,792 to 28,988) |
0.02 |
16,731 (8,001 to 27,241) |
0.004 |
|
MMP-9 |
377,000 (258,488 to 607,190) |
421,409 (248,758 to 627,056) |
547,697 (344,692 to 802566) |
0.01 |
466,416 (284,003 to 730,264) |
0.04 |
|
CXCL8 |
27.0 (21.1 to 40.5) |
30.0 (23.2 to 53.0) |
34.0 (20.1 to 88.9) |
0.4 |
31.9 (21.3 to 52.2) |
0.2 |
|
HGF |
421.7 (327.8 to 678.3) |
430.3 (305.9 to 648.3) |
408.4 (337.7 to 555.2) |
1.0 |
427.1 (327.8 to 646.1) |
0.9 |
|
|
||||||
|
HGF, hepatocyte growth factor; MMP, matrix metalloproteinase. aKruskal-Wallis test. bEver smoked versus never smoked (Mann-Whitney U test). |
||||||
|
Mattey et al. Arthritis Research & Therapy 2012 14:R127 doi:10.1186/ar3857 |
||||||